Precision Medicine market continues to demonstrate strong momentum within the healthcare and life sciences landscape. Valued at USD 130,400 million in 2024, the market is projected to reach USD 256,430 million by 2031, expanding at a compound annual growth rate (CAGR) of 10.4% during the forecast period. This robust expansion highlights the growing shift toward individualized...

Autonomous Delivery Robots Are Rapidly Transforming Last Mile Logistics Into a Smarter Faster and More Resilient Ecosystem The race to redefine last-mile delivery is no longer just about speed it is about intelligence, adaptability, and long-term sustainability. Autonomous delivery robots are stepping into this space as a breakthrough solution, helping businesses navigate rising operational...

The Global Deep Hyperthermia Devices Market continues to gain momentum as thermal oncology and precision-based cancer care advance across healthcare systems worldwide.  According to the latest analysis, the market was valued at USD 434 million in 2024 and is projected to reach USD 641 million by 2031, registering a 5.8% CAGR during the forecast period. The expanding demand for targeted,...

The anti-PD-1 antibody industry is experiencing significant momentum as immunotherapy continues to transform cancer treatment approaches worldwide. Growing investments in oncology research, expanding clinical applications, and increasing awareness of immune checkpoint inhibitors are creating new opportunities across healthcare systems. The Global Anti-PD-1 Antibody Market Future Trends reflect...

According to a newly published market research report by 24LifeSciences, the global BNCT boron drug market was valued at USD 72 million in 2024 and is projected to reach USD 160 million by 2031, growing at a compound annual growth rate (CAGR) of 12.3% during the forecast period. BNCT boron drugs comprise highly specialized pharmaceutical agents designed to selectively deliver boron-10 isotopes...

According to a newly published market research report by 24LifeSciences, Global Lenvatinib Mesylate Capsules Market was valued at USD 1.3 billion in 2024 and is projected to reach USD 2.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 20252032. Lenvatinib Mesylate, commercially known as Lenvima, is a multi-kinase inhibitor specifically...

The genome-based drug industry is transforming modern healthcare by enabling highly targeted therapies based on an individual's genetic profile. Advances in genomic science and molecular diagnostics are creating new possibilities for treating complex and inherited diseases. Growing adoption of precision medicine, increased investment in biotechnology research, and rapid developments in gene...

Cancer treatment is undergoing a major transformation with the emergence of innovative biological therapies that selectively target tumor cells while stimulating the immune system. Among these advanced approaches, oncolytic virus therapy has gained significant attention due to its potential to improve treatment outcomes across multiple cancer types. Increasing research investments,...

Global Digital Pathology (Whole Slide) Image Sensor Market, valued at a robust US$ 520 million in 2024, is on a trajectory of significant expansion, projected to reach US$ 1.05 billion by 2032. This growth, representing a compound annual growth rate (CAGR) of 9.2%, is detailed in a comprehensive new report published by Semiconductor Insight. The study highlights the critical role of these...

Tumor mice model market is witnessing sustained growth as oncology research intensifies and pharmaceutical companies seek more predictive preclinical platforms. Valued at USD 1.82 billion in 2024, the market is projected to reach USD 2.92 billion by 2031, expanding at a compound annual growth rate (CAGR) of 7.1% during the forecast period from 2025 to 2032. Discover Market Highlights –...